TOBEVIBART
UNII PL93ZHC4L3

Substance Identification & Data

This profile provides standardized clinical and technical data for Tobevibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PL93ZHC4L3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2645440-65-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PL93ZHC4L3

CAS Registry Number

2645440-65-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TOBEVIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190476

National Cancer Institute reference terminology for clinical and research data.

INN ID

12316

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-79

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tobevibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOBEVIBART

Common Names & Synonyms

IMMUNOGLOBULIN G1 (238-ALANINE,332-LEUCINE,334-GLUTAMIC ACID,430-LEUCINE,436-SERINE), ANTI-(HEPATITIS B VIRUS SURFACE ANTIGEN) (HUMAN MONOCLONAL VIR-3434 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIR-3434 .LAMBDA.-CHAIN, DIMER

TOBEVIBART [INN]

TOBEVIBART [USAN]